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INTRODUCTION 
The use of ozone, intra or periarticular, for knee and hip joint osteoarthritis 
(KO / HO) is clearly justified by its anti-inflammatory and antioxidants 
properties, that should diminish the arthritic episodes of this disease [1]. 
Several papers have proved the safety and efficacy of this treatment for KO 
[2-12], comparable to other classical treatments (steroids or hyaluronic acid 
(HA)) [13-14]. However, there is no paper about HO yet. 

STUDY DESIGN 
This work is based on two open prospective studies started in February 
2002 and stopped in February 2010, one group for each joint. Recruitment 
criteria for both groups were: 





• No previous joint trauma 

• No rheumatic disorder 

• No previous surgery (but arthroscopic meniscectomy) 

- NSAIDs for at least two months 

- Promise to abandon any anti-inflammatory drugs during ozone 
treatment 

- Informed consent 

Clinical evaluation for KO was done using WOMAC questionnaire, pre-
treatment and 1, 3, 6, 12 months after treatment. In case of HO, we used 
VAS for evaluation instead. 

CLINICAL DATA 
All patients have, at least, 12 months follow-up. For KO, we have complied 
199 patients (225 knees). There are two missing cases, not compiled, due to 
death at the 1 year revision. Age of sample ranged from 51 to 89 during the 








Other data compiled, were: age, gender, BMI, Kellgren & Lawrence 
radiological scale (I to IV) and relapses (time free of symptoms). For HO, we 
have compiled 126 patients (133 hips). There are no missing cases at one 
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Other data compiled, were: age, gender, BMI, use of imaging, Kellgren & 
Lawrence radiological scale (I to IV) and relapses (time free of symptoms). 

OZONE TECHNIQUE: All patients got one intarticular injection of ozone, once a 
week; in case of associated tendinitis or bursitis, a second or third injection 
was done together the intrarticular one. Injections were performed under 
strict asepsy. For the knee, we used a 27G x 30 mm needle with a 
syliconized syringe and a supero-lateral approach and. Ozone dose for 
intraticular injection was 15 mL at 20 mcg/mL.[15-16] Paratendon injection 
was performed with 5 mL at 20 mcg/mL. We always did a minimun of three 
intrarticular injections. Patients that did not improve were classified as 
failure. For the rest of the patients, the average number of injections was 4,8 
(range 3 to 7). For the hip, we used a 25G x 90 mm needle with a 
syliconized syringe and a lateral approach. Ozone dose for intraticular 
injection was 5-10 mL at 20 mcg/mL.[15-16] Paratendon injection was 
performed with 5 mL at 20 mcg/mL. 45 patients were injected with imaging 
guide due to severe obesity. In these patients we used a 22G x 205 mm 
needle. We always did a minimun of three intrarticular injections. Patients 
that did not improve were classified as failure. For the rest of the patients, 
the average number of injections was 5 (range 3 to 10). 

RESULTS 
From 225 knees, 44 (19.5% - the “bad result” group) did almost not improve 
at all; other rescue treatments were offered. The rest (80.5%) achieved a 
significant improvement, increasing WOMAC index over 25% of their basal 
level. The clinical improvement was obtained during the treatment or the 
first three months after treatment. WOMAC global improvement was 48%, 
including both groups. Relapses over the “good result” group have been of 
8% at 1 year revision, and are statistically related just with Kellgren & 
Lawrence classification. We registered no side effect that needed further 
treatment. From 133 hips, 80% improved at least 2 points in VAS and 73% 
improved at least 3 points. The one month follow-up VAS score was 3,3 
(improvement of 55%). From the patients that improved, 25% had a relapse 
at 1 year visit, and are statistically related just with Kellgren & Lawrence 
classification. The use of imaging support did not improved the results. We 
registered no side effect that needed further treatment. 

DISCUSSION 
Results for KO are similar to Moretti's paper [12] and similar to the ones 
published for HA papers [15]. These last papers are almost always referred 
to 6 month follow-up. Comparing our results with HA papers at one year 
follow-up, they are clearly better. Longer term results for HA are even worse. 
This study has flaws due to its design, but similar design has been used for 
reporting results about drugs, HA or surgery, so comparison can be done. 
For HO, the results are even better that the one published for steroids or HA 




Ozone treatment in KO improves clinical outcomes over 25% of its base 
level in more than 80% of the patients. Relapse rate is 8% and is related 
with advanced osteoarthritis (Kellgren & LAwrence grades III-IV); minimal 
time free of symptoms is almost one year. The similarity with Moretti's 
results in a double blind clinical trial strength the indication for ozone in 
patients with KO. No paper has been published yet about HA, but 
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